TipRanks
Go Ultimate55% OFF

Hikma Pharmaceuticals (H5P) Balance Sheet

Hikma Pharmaceuticals Balance Sheet

Hikma Pharmaceuticals's total assets for Q2 2026 were $5.86B, an increase of 3.30% from the previous quarter. DE:H5P total liabilities were $3.31B for the fiscal quarter, a 7.92% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 5.67B$ 5.13B$ 4.68B$ 4.47B$ 4.37B
$ 3.07B$ 2.81B$ 2.47B$ 2.32B$ 1.91B
$ 2.61B$ 2.32B$ 2.21B$ 2.15B$ 2.47B

Currency in USD

Hikma Pharmaceuticals Debt to Assets

02B4B6B42 %48 %54 %60 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets